ATRA (atarabio.com) Net Profit

ATRA (atarabio.com) - company brandmark

Atara Biotherapeutics (ATRA) maintains its position in multiple sclerosis therapy thanks to strong patent protection. The company is developing the Ebvallo system to treat post-transplant complications, creating a closed therapeutic cycle. However, fierce competition from biotech behemoths increases risks. The company's current profit on this chart reflects revenue dynamics, where -0.02 determines the current value of the indicator.

ATRA (Atara Biotherapeutics) Net Profit history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company atarabio.com (ATRA)

- price and consensus price forecast:
Stock Quotes Atara Bio|ATRA - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization ATRA|ATRA - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Atara Biotherapeutics|ATRA - Book Capitalization|Market Capitalization to Book Value atarabio.com|ATRA - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Atara Biotherapeutics|ATRA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Atara Bio|ATRA - Company Total Debt|Debts to Book Capitalization ATRA|ATRA - Company Long-Term Debt|Company Short-Term Indebtedness Atara Biotherapeutics|Immediate Liquidity atarabio.com
- net income and valuation multiples indicators:
ATRA - Net Profit
Summary company analysis:Atara Biotherapeutics
Core merchandise of Atara Biotherapeutics, Inc.

Assessing the investment reliability of equity assets requires separating real returns from market noise by analyzing the net financial result minus all expenses. This financial performance metric reflects the efficiency of monetizing cell technologies, accounting for ESG optimization costs for bio-waste, allowing investors to determine the sustainability of the Atara Biotherapeutics (ATRA) business model via this chart.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|NKTR (Nektar Therapeutics) - Net Income|UPB: Profit After Payment of Taxes|ZBIO (Zenas Biopharma) - Net Profit|Net Profit Immunome Inc|Company Net Income Gossamer Corp (GOSS)|KALV (KalVista Corp) - Final Profit|Net Profit SEPN (Septerna Inc)|Net Profit pieris.com PVLA|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB: Net Profit|ATXS (Astria Corp) - Company Net Income|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS - Company Net Income|Kyverna - Net Income|Profit After Payment of Taxes TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Net Profit|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|Company Net Income Avalo Therapeutics, Inc. (AVTX)|Company Net Income Eledon|AGEN: Final Profit|Net Profit CLYM|Net Profit zurabio.com (ZURA)|Company Net Income aTyr Pharma ATYR|ADAG (Adagene Inc) - Profit After Tax|Ikena Oncology, Inc. - Net Profit|Company Net Income Shattuck Labs, Inc.|EQ (equilliumbio.com) - Net Income|Connect Biopharma Holdings Limited (CNTB) - Net Profit|Net Income IMUX|IFRX (InflaRx GmbH) - Profit After Payment of Taxes|Net Profit XFOR|Net Financial Result adicetbio.com|Net Profit CELU (Celularity)|INMB - Net Income|BRNS - Company Net Income|Net Financial Result Kezar Life Sciences Inc. KZR|SABS: Net Profit|Akari Therapeutics, Plc (AKTX) - Net Profit|Net Income ENLV|QTTB (Q32 Bio Corp) - Profit After Payment of Taxes|Company Net Income GeoVax (GOVX)|EDSA (Edesa Biotech Inc) - Final Profit|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTLB - Company Net Income|Profit After Tax BOLT|HCWB: Net Profit|Aptevo Therapeutics Inc. - Final Profit|AIM (AIM ImmunoTech) - Net Profit|Net Profit Aditxt Corp|Company Net Income GRI Bio, Inc. (GRI)|XRTX (xortx.com) - Final Profit|Company Net Income Vyome Holdings HIND|REVB - Net Income|Indaptus - Net Profit|SCNI - Net Profit|CALI (calcimedica.com) - Net Income|Affimed N.V. - Final Profit|ALLK (Allakos Inc) - Net Profit|HOOKIPA (HOOK) - Net Financial Result|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP - Net Income|THRD: Net Income